A wealth of evidence supports the role of tumor immunotherapy as a vital therapeutic option
in cancer. In recent decades, accumulated studies have revealed the anticancer activities of …

Apoptotic cells have long been considered as intrinsically tolerogenic or unable to elicit
immune responses specific for dead cell-associated antigens. However, multiple stimuli can …

Despite advances in treatments like chemotherapy and radiotherapy, metastatic cancer
remains a leading cause of death for cancer patients. While many chemotherapeutic agents …

The platinum-based drugs cisplatin, carboplatin, and oxaliplatin belong to the most widely
used chemotherapeutics in oncology, showing clinical efficacy against many solid tumors …

The immunogenic demise of cancer cells can be induced by various chemotherapeutics,
such as anthracyclines and oxaliplatin, and provokes an immune response against tumor …

Dendritic cells (DC) are unique hematopoietic cells, linking innate and adaptive immune
responses. In particular, they are considered as the most potent antigen presenting cells …

The term “immunogenic cell death”(ICD) is now employed to indicate a functionally peculiar
form of apoptosis that is sufficient for immunocompetent hosts to mount an adaptive immune …

Immunogenic cell death (ICD), which is triggered by exposure of tumor cells to a limited
range of anticancer drugs, radiotherapy, and photodynamic therapy, represents a recent …

Plants contain numerous glycoconjugates that are metabolized by specific
glucosyltransferases and hydrolyzed by specific glycosidases, some also catalyzing …

The concentration of sodium ions (Na+) is raised in solid tumours and can be measured at
the cellular, tissue and patient levels. At the cellular level, the Na+ gradient across the …